Linatab M 2.5/500 Tablet
৳ 120
- Combination of DPP-4 inhibitor and बिगuanide
- Dual mechanism for effective blood glucose control
- Linagliptin enhances incretin hormones
- Metformin reduces hepatic glucose production
- Low risk of hypoglycemia when used appropriately
- Suitable for combination therapy in type 2 diabetes
- Once or twice daily dosing (as prescribed)
Linatab M 2.5/500 Tablet is a fixed-dose combination of Linagliptin and Metformin Hydrochloride, used in the management of type 2 diabetes mellitus. Linagliptin, a DPP-4 inhibitor, increases incretin hormone levels, leading to glucose-dependent insulin release and reduced glucagon secretion. Metformin, a बिगuanide, decreases hepatic glucose production and improves insulin sensitivity.
This combination provides complementary mechanisms to achieve better glycemic control compared to monotherapy. It is commonly prescribed when blood sugar levels are not adequately controlled with a single agent.
Linatab M should be taken with meals to reduce gastrointestinal side effects associated with Metformin. The dosage is determined by a registered physician based on the patient’s condition and response to therapy. Regular monitoring of blood glucose levels is essential during treatment.
Unit Price: 12.00 Tk
Strip Price: 120.00 Tk
Reviews
There are no reviews yet.